glutathione-responsive prodrug

glutathione-responsive prodrug GSH-triggered drug release and the responsive mechanism of PDF) Glutathione responsive iNOS inhibiting

Name: glutathione-responsive prodrug GSH-triggered drug release and the responsive mechanism of PDF) Glutathione responsive iNOS inhibiting
Brand: southroadsurgery.com.au
SKU: 85438404997
Price: 27.00 USD
Availability: InStock
Rating: 4.1746 (21 reviews)

PDF) Glutathione responsive iNOS inhibiting polymeric prodrug for targeted Inhibition of angiogenesis A GSH Activatable Theranostic Prodrug Based on Photoinduced Electron Transfer for Cancer Fluorescence Imaging and Therapy A glutathione triggered precision explosive system for improving tumor chemosensitivity Nano Research Springer Nature Link Emerging Strategies in Stimuli Responsive Prodrug Nanosystems for Cancer Therapy ACS Nano Activatable theranostic prodrug scaffold with tunable drug release rate for sequential photodynamic and chemotherapy Wang 2024 Smart Molecules Wiley Online Library Redox Responsive Polyprodrugs: Recent Innovations in Reduction and Oxidation Responsive Drug Delivery Systems Chemistry of Materials

SKU: 85438404997 · From southroadsurgery.com.au

4.2

USD27.00 USD73.00

Pay in 4 interest-free payments of $6.75 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

Taking advantage of the fact that they can be reduced by thiols that exist in the cell cytoplasm, such as glutathione, ADCs have been engineered to be conjugated to the disulfide linkers that remain stable in the circulation and selectively release drugs in the cytoplasm

Burkholderia pseudomallei Rapidly Infects the Brain Stem and Spinal Cord via the Trigeminal Nerve after Intranasal Inoculation

The Bibbidi Bobbidi Boo Cake just debuted at Disney to celebrate the 70th anniversary of the beloved animated film, and the entire thing is almost too enchanting to eat

Science 330 (6009), 13401344

[DOI] [PMC free article] [PubMed] [Google Scholar] (205).Rizk M

Emerging CAR-macrophage (CAR-M) platforms, exemplified by anti-HER2 CAR-Ms, not only mediate the direct phagocytosis of tumor cells but also potentiate antigen presentation and pro-inflammatory cytokine release (187)